Related Articles
O‑GlcNAcylation enhances anaplastic thyroid carcinoma malignancy
O-GlcNAcylation promotes migration and invasion in human ovarian cancer cells via the RhoA/ROCK/MLC pathway
O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy
Aberrant O-GlcNAc-modified proteins expressed in primary colorectal cancer
O-GlcNAcylation is increased in prostate cancer tissues and enhances malignancy of prostate cancer cells